Does LEUPROLIDE Cause Epistaxis? 107 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Epistaxis have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.2% of all adverse event reports for LEUPROLIDE.
107
Reports of Epistaxis with LEUPROLIDE
0.2%
of all LEUPROLIDE reports
6
Deaths
33
Hospitalizations
How Dangerous Is Epistaxis From LEUPROLIDE?
Of the 107 reports, 6 (5.6%) resulted in death, 33 (30.8%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which LEUPROLIDE Alternatives Have Lower Epistaxis Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM